147 search results for: patient burden

ERS 2025 | Type 2 Severe Asthma "Unplugged": Reducing Mucus to Improve Long-term <b>Patient</b> Outcomes
Pulmonology
ERS 2025 | Type 2 Severe Asthma "Unplugged": Reducing Mucus to Improve Long-term Patient Outcomes
videoanimation

Join leading pulmonologists Drs. Njira Lugogo, Simon Couillard, and Mario Castro, as they explore the role of type 2 inflammation in the pathogenesis of mucus plugging in the airways, the burden of excess mucus in patients with moderate-to-severe asthma, and how reducing airway mucus may lead to improved long-term patient outcomes.

View more
Event Page Thumbnail
Congress
27
April
2026
Congress
ADVENT at CEORL-HNS 2026

Join Sanofi and Regeneron for an educational symposium on type 2 inflammation, patient characteristics predictive of disease recurrence, and emerging real-world evidence for biologics in CRSwNP.

Lung Function Decline: Why it Matters and What’s at Stake for <b>Patient</b>s
Pulmonology
Lung Function Decline: Why it Matters and What’s at Stake for Patients
interactivity

Understand the drivers of lung function decline in chronic obstructive pulmonary disease (COPD), including chronic inflammation, key risk factors, and the impact on patient well-being .

View more
Diagnosis of Bullous Pemphigoid Interactive <b>Patient</b> Case
Dermatology
Diagnosis of Bullous Pemphigoid Interactive Patient Case
interactivity

An interactive patient case tool involving a deeper dive into assessing clinical presentation when diagnosing bullous pemphigoid (BP)

View more
Pathways to Disease: Inflammation in Chronic Obstructive Pulmonary Disease Video
Pulmonology
Pathways to Disease: Inflammation in Chronic Obstructive Pulmonary Disease Video
videoanimation

Learn about the significant burden that patients with COPD experience and the role of inflammatory mechanisms in this chronic, often progressive disease. 

View more
ESPGHAN 2024 | Shedding Light on Pediatric Eosinophilic Esophagitis: Timely Identification and Management
On Demand
ESPGHAN 2024 | Shedding Light on Pediatric Eosinophilic Esophagitis: Timely Identification and Management

Prof. Salvatore Oliva and Dr. Dhandapani Ashok discuss the burden of type 2 inflammation in pediatric EoE and the importance of early diagnosis and management.

Pediatric Asthma <b>Patient</b> Case Tool: Ash
Pulmonology
Pediatric Asthma Patient Case Tool: Ash
interactivity

Review a patient case to learn more about identifying uncontrolled asthma and type 2 inflammation in pediatric patients

View more
ADVENT On Air | Exploring The Urgency to Treat in Atopic Dermatitis
Dermatology
ADVENT On Air | Exploring The Urgency to Treat in Atopic Dermatitis
Podcast

Professor Lisa Beck explores the chronic and persistent burden of atopic dermatitis (AD) as well as the concept of early intervention in patients with AD.

View more
ADVENT at ERS 2024
On Demand
ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation

Join experts Henrik Watz, Mona Bafadhel, and Alberto Papi for an educational symposium on the link between underlying drivers of COPD with type 2 inflammation and cumulative patient burden, exploring the role of type 2 cytokines, and current and emerging therapies.

Adult Asthma Interactive <b>Patient</b> Cases
Pulmonology
Adult Asthma Interactive Patient Cases
interactivity

Explore 3 hypothetical patient cases using guideline-based checklists for assessment and diagnosis of type 2 inflammation in adult asthma

View more
Type 2 Inflammation Underpins Pediatric Severe Asthma
Pulmonology
Type 2 Inflammation Underpins Pediatric Severe Asthma
Infographic

Learn about the role type 2 inflammation plays in the burden and pathophysiology of severe asthma in pediatric patients.

View more
Spotlight on Type 2 Inflammation in the Upper and Lower Airways
Pulmonology
Spotlight on Type 2 Inflammation in the Upper and Lower Airways
expert video

In this video soundbite from the EAACI 2025 symposium, Dr. Zuzana Diamant explains pathophysiological mechanisms underlying asthma and CRSwNP, and how type 2 inflammatory cytokines drive airway remodelling in patients with severe asthma. Additionally, patients with co-existing asthma and CRSwNP have a higher type 2 inflammatory burden than patients with asthma alone.

View more